ProMIS Neurosciences Inc.

For the period ended Mar 31, 2025. Filed May 12, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 12, 2025

PMN$4.05-2.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets


· · March 31, · · December 31, ·
· 2025 · 2024 ·
Assets
Current assets:
Cash	$8,364,301	$13,291,167
Short-term investments	33,051	33,051
Prepaid expenses and other current assets	5,249,319	5,587,238
Total current assets	13,646,671	18,911,456
Total assets	$13,646,671	$18,911,456
Liabilities and Shareholders' Equity
Current liabilities:
Accounts payable	$1,200,162	$1,737,463
Accrued liabilities	2,856,086	480,962
Total current liabilities	4,056,248	2,218,425
Share-based compensation liability	113,100	199,263
Warrant liability	5,592	5,592
Total liabilities	4,174,940	2,423,280

Commitments and contingencies
Shareholders' equity:
Common shares, no par value, unlimited shares authorized, 32,689,190 shares issued and outstanding as of March 31, 2025 and December 31, 2024	—	—
Additional paid-in capital	107,877,891	107,546,433
Accumulated other comprehensive loss	(371,184)	(371,184)
Accumulated deficit	(98,034,976)	(90,687,073)
Total shareholders' equity	9,471,731	16,488,176
Total liabilities and shareholders' equity	$13,646,671	$18,911,456

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.